Latest Conference Articles

 AAO 2020: Study outlines use of injectable intraocular steroid over drops

AAO 2020: Study outlines use of injectable intraocular steroid over drops

November 16th 2020

AAO

Robert Weinstock, MD, presents data from a retrospective multicenter study focusing on the efficacy of dexamethasone intraocular suspension 9% delivered at the time of cataract surgery.

AAO 2020: Fingolimod for MS offers disease control with no development of uveitis

AAO 2020: Fingolimod for MS offers disease control with no development of uveitis

November 15th 2020

AAO

Bradley Smith, MD, presents at AAO 2020 on how fingolimod 0.5 mg, a first-line treatment for multiple sclerosis, may reduce both the number of relapses and disease progression in patients with relapsing-remitting MS as well as the incidence of uveitis.

AAO 2020: Drop-free prophylaxis regimen before cataract surgery lowers treatment burden with caveats

AAO 2020: Drop-free prophylaxis regimen before cataract surgery lowers treatment burden with caveats

November 15th 2020

AAO

During AAO 2020, Neal H. Shorstein, MD, explains how physicians at Kaiser Permanente have a streamlined regimen using a prophylactic drop-free drug before cataract surgery for more than a decade.

AAO 2020: Preventing cystoid macular oedema after cataract surgery

AAO 2020: Preventing cystoid macular oedema after cataract surgery

November 15th 2020

AAO

Rudy Nuijts of the University Eye Clinic Maastricht, the Netherlands, discusses the highlights of his AAO 2020 presentation on a combination treatment regimen for lowering the incidence of cystoid macular oedema following category surgery.

AAO 2020: Alcon showcases advanced IOL technology for presbyopia

AAO 2020: Alcon showcases advanced IOL technology for presbyopia

November 15th 2020

AAO

Kristen Brotherson, vice president, US surgical marketing for Alcon, discusses some of the recent advances in cataract surgery-related technologies, including a new advanced lens for patients with presbyopia (AcrySof IQ Vivity IOL).

 AAO 2020: Medication could reduce burden of steroid drops for patients

AAO 2020: Medication could reduce burden of steroid drops for patients

November 15th 2020

AAO

Cynthia Matossian, MD, FACS, ABES presents the highlights of a poster on outcomes with dexamethasone intraocular suspension 9% and concomitant postoperative anti-inflammatory medications.

AAO 2020: Alimera highlights NEW DAY Study for sustained-release intravitreal implant

AAO 2020: Alimera highlights NEW DAY Study for sustained-release intravitreal implant

November 15th 2020

AAO

Rick Eiswirth, president and CEO of Alimera Sciences, provides an update on the company’s clinical trial that aims to evaluate its fluocinolone acetonide intravitreal implant 0.19 mg (Iluvien) as a baseline therapy for diabetic macular edema.

AAO 2020: Headache paired with visual loss may require honing of detective skills

AAO 2020: Headache paired with visual loss may require honing of detective skills

November 14th 2020

AAO

During AAO 2020, Kathleeen B. Digre, MD, details how a headache in conjunction with visual loss is a scenario that requires an in-depth examination, including evaluation of the visual fields, pupils, and fundus to gather clues to the diagnosis.

AAO 2020: Autologous retinal transplant for larger macular holes gaining traction

AAO 2020: Autologous retinal transplant for larger macular holes gaining traction

November 14th 2020

AAO

Tamer Mahmoud, MD, PhD, discusses autologous retinal transplant (ART) for macular holes, a procedure he developed, which is providing anatomic hole closure in the vast majority of cases as well as increases in visual acuity.

AAO 2020: Myopia progression slowed with multifocal and orthokeratology lenses

AAO 2020: Myopia progression slowed with multifocal and orthokeratology lenses

November 14th 2020

AAO

In a presentation at the American Academy of Ophthalmology’s virtual 2020 annual meeting, Amy K. Hutchinson, MD, explained that while Myopia has been occurring at epidemic rates worldwide, research has found that the use of orthokeratology and multifocal contact lenses can provide clinically meaningful reductions in myopia progression.